BiondVax Pharmaceuticals Ltd ADR is a biotechnology business based in the US. BiondVax Pharmaceuticals Ltd ADR shares (BVXV) are listed on the NASDAQ and all prices are listed in US Dollars. BiondVax Pharmaceuticals Ltd ADR employs 15 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy BiondVax Pharmaceuticals Ltd ADR stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – BVXV. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
What's in this guide?
BiondVax Pharmaceuticals Ltd ADR stock price (NASDAQ: BVXV)Use our graph to track the performance of BVXV stocks over time.
BiondVax Pharmaceuticals Ltd ADR shares at a glance
|Latest market close||$2.56|
|52-week range||$2.37 - $22.90|
|50-day moving average||$5.47|
|200-day moving average||$9.66|
|Wall St. target price||$57.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.30|
Buy BiondVax Pharmaceuticals Ltd ADR stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy BiondVax Pharmaceuticals Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BiondVax Pharmaceuticals Ltd ADR price performance over time
|1 week (2023-01-27)||-1.92%|
|1 month (2023-01-04)||-14.09%|
|3 months (2022-11-04)||204.76%|
|6 months (2022-08-04)||113.33%|
|1 year (2022-02-04)||91.04%|
|2 years (2021-02-04)||-45.30%|
|3 years (2020-02-04)||10.08|
|5 years (2018-02-02)||6.7899|
BiondVax Pharmaceuticals Ltd ADR financials
|Gross profit TTM||$0|
|Return on assets TTM||-20.98%|
|Return on equity TTM||-432.25%|
|Market capitalisation||$4.9 million|
TTM: trailing 12 months
BiondVax Pharmaceuticals Ltd ADR share dividends
We're not expecting BiondVax Pharmaceuticals Ltd ADR to pay a dividend over the next 12 months.
Have BiondVax Pharmaceuticals Ltd ADR's shares ever split?
BiondVax Pharmaceuticals Ltd ADR's shares were split on a 1:10 basis on 25 November 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BiondVax Pharmaceuticals Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for BiondVax Pharmaceuticals Ltd ADR shares which in turn could have impacted BiondVax Pharmaceuticals Ltd ADR's share price.
BiondVax Pharmaceuticals Ltd ADR share price volatility
Over the last 12 months, BiondVax Pharmaceuticals Ltd ADR's shares have ranged in value from as little as $2.37 up to $22.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BiondVax Pharmaceuticals Ltd ADR's is 2.5842. This would suggest that BiondVax Pharmaceuticals Ltd ADR's shares are significantly more volatile than the average for this exchange and represent a higher risk.
BiondVax Pharmaceuticals Ltd ADR overview
BiondVax Pharmaceuticals Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. .
BiondVax Pharmaceuticals Ltd ADR in the news
BiondVax Presenting at BIO CEO & Investor Conference
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
Frequently asked questionsWhat percentage of BiondVax Pharmaceuticals Ltd ADR is owned by insiders or institutions?
Currently 27.747% of BiondVax Pharmaceuticals Ltd ADR shares are held by insiders and 13.232% by institutions. How many people work for BiondVax Pharmaceuticals Ltd ADR?
Latest data suggests 15 work at BiondVax Pharmaceuticals Ltd ADR. When does the fiscal year end for BiondVax Pharmaceuticals Ltd ADR?
BiondVax Pharmaceuticals Ltd ADR's fiscal year ends in December. Where is BiondVax Pharmaceuticals Ltd ADR based?
BiondVax Pharmaceuticals Ltd ADR's address is: Jerusalem BioPark Building, Jerusalem, Israel What is BiondVax Pharmaceuticals Ltd ADR's ISIN number?
BiondVax Pharmaceuticals Ltd ADR's international securities identification number is: US09073Q1058 What is BiondVax Pharmaceuticals Ltd ADR's CUSIP number?
BiondVax Pharmaceuticals Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 09073Q105
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert